{"id":374,"date":"2024-08-03T07:39:34","date_gmt":"2024-08-03T07:39:34","guid":{"rendered":"https:\/\/diabetesasia.org\/journal\/?page_id=374"},"modified":"2026-05-18T15:48:09","modified_gmt":"2026-05-18T15:48:09","slug":"about-us","status":"publish","type":"page","link":"https:\/\/www.diabetesasia.org\/journal\/about-us\/","title":{"rendered":"About Us"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"creative\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"open\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0\"orcid\"<\/p>\n

This is an open-access journal, meaning that all content is freely available to the user or his\/her institution without charge.<\/span> Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is by the Budapest Open Access Initiative (BOAI) definition of open access<\/p>\n

The articles in Diabetes Asia Journal under JHRC is open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

https:\/\/portal.issn.org\/resource\/ISSN\/3048-8192<\/a><\/p>\n\n\n\n\n\n\n\n\n\n
\n

Publisher<\/strong><\/p>\n<\/td>\n

\n

Diabetes Asia Journal under JHRC<\/p>\n<\/td>\n<\/tr>\n

\n

Started<\/strong><\/p>\n<\/td>\n

\n

2024<\/p>\n<\/td>\n<\/tr>\n

\n

Frequency<\/strong><\/p>\n<\/td>\n

\n

Quarterly<\/p>\n<\/td>\n<\/tr>\n

\n

Language<\/strong><\/p>\n<\/td>\n

\n

English<\/p>\n<\/td>\n<\/tr>\n

\n

Subject<\/strong><\/p>\n<\/td>\n

\n

Diabetes<\/p>\n<\/td>\n<\/tr>\n

\n

Format<\/strong><\/p>\n<\/td>\n

\n

PDF<\/p>\n<\/td>\n<\/tr>\n

\n

ISSN (Online)<\/strong><\/p>\n

Journal DOI<\/span><\/p>\n<\/td>\n

\n

3048-8192<\/p>\n

doi.org\/10.62996\/daj.10002024<\/i><\/span><\/p>\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

1. Aims and Scope:\u00a0<\/b><\/h4>\n

Diabetes Asia Journal<\/a> under JHRC is an innovative, research, online, open-access, single-blind peer-reviewed\u00a0<\/i><\/b>Journal<\/strong><\/em><\/span> that accepts solicited and unsolicited manuscripts. Articles published in the Diabetes Asia Journal under JHRC<\/span>\u00a0are Superior-quality, clinical, and basic, influential research articles by established academic authors and new researchers. The paramount objective of<\/span>\u00a0<\/span>the <\/span>Journal is to encourage and promote distinguished research in diabetes, hypertension, maternal-fetal medicine, gestational diabetes, and NCD health, as well as inspire and motivate all contributors to advance the field. The articles published in<\/span>\u00a0<\/em>Diabetes Asia Journal\u00a0under JHRC include Editorial, Correspondence, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Meta-analysis, Evidence-based Medicine, Clinical Guidelines, Letter to the Editor, and Case Report.\u00a0<\/span><\/p>\n

Diabetes Asia Journal\u00a0is published under JHRC and covers\u00a0Diabetes Research, including NCDs, specifically in Central Asia, South Asia, Southeast Asia,<\/em><\/span> and the Asia Pacific.<\/i><\/p>\n

2. APC: Article processing charges are completely waived for 2 years from Jan 2024 to Jan 2026
<\/span>All the articles are Open Access and are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third-party material in this article are included in the article\u2019s Creative Commons license unless stated otherwise in a credit line to the material. Suppose the material is not included in the article\u2019s Creative Commons license, and your intended use is prohibited by statutory regulation or exceeds the permitted use. In that case, you must obtain permission directly from the copyright holder. To view a copy of this license, visit http:\/\/creativecommons.org\/licenses\/by\/4.0\/<\/a>\u00a0<\/span>\u00a0<\/span><\/p>\n

4. Diabetes Asia Journal routinely screens article submissions for plagiarism
<\/i>\u00a0through\u00a0<\/span>https:\/\/www.ithenticate.com\/products\/crossref-similarity-check and accepts less than 10% similar content.
<\/span><\/span><\/i>5. Repository as a preprint can be deposited on the Journal website, for which a DOI preprint will be given and available till the article is published.
<\/i>4. Diabetes Asia Journal routinely screens article submissions for plagiarism\u00a0<\/i>\u00a0through\u00a0<\/span>https:\/\/www.ithenticate.com\/products\/crossref-similarity-check and accepts less than 10% similar content.
<\/span><\/span><\/i>5. Repository as a preprint can be deposited on the Journal website, for which a DOI preprint will be given and available till the article is published.
<\/i>
<\/i>\u00a0<\/p>\n

<\/figure>\n

<\/p>\n

<\/p>\n

\"\"<\/figure>\n

<\/p>\n

6. Diabetes Asia Journal under JHRC is a signatory of the Declaration on Research Assessment\u00a0(DORA)<\/a>, which emphasizes continued improvement in evaluating researchers and scholarly research outputs.<\/p>\n

<\/p>\n

7. Diabetes Asia Journal under JHRC is a publisher and a Member of Crossref<\/a> with DOI: 10.62996<\/p>\n

<\/p>\n

\"\"<\/figure>\n

<\/p>\n

\"\"https:\/\/sfdora.org\/signers\/?_signers_keyword=Diabetesasia&_organization_country=india<\/figure>\n

<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Diabetes Asia Journal is an open-access journal, meaning that all content is freely available to users or their institutions without charge. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is the definition of open access, as defined by the Budapest Open Access Initiative (BOAI). The articles in Diabetes Asia Journal under JHRC, Open Access, and are licensed under a Creative Commons Attribution 4.0 International License, visit http:\/\/creativecommons.org\/licenses\/by\/4.0\/, and the authors retain all rights, which permits unrestricted, non-commercial use, distribution, and reproduction in any medium, provided the work is properly cited. https:\/\/portal.issn.org\/resource\/ISSN\/3048-8192 Publisher Diabetes Asia Journal under JHRC Started 2024 Frequency Quarterly Language English Subject Diabetes Format PDF ISSN (Online)Journal DOI 3048-8192doi.org\/10.62996\/daj.10002024 1. Aims and Scope:\u00a0 Diabetes Asia Journal under JHRC is an innovative, research, online, open-access, single-blind peer-reviewed\u00a0Journal that accepts solicited and unsolicited manuscripts. Articles published in the Diabetes Asia Journal under JHRC are of Superior Quality, clinical and basic, and influential, and include research by established academic authors and new researchers. The paramount objective of the Journal is to encourage and promote distinguished research in diabetes, hypertension, maternal-fetal medicine, gestational diabetes, and NCD health, and to inspire and motivate all contributors to advance the field. The articles published in\u00a0Diabetes Asia Journal under JHRC include Editorial, Correspondence, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Meta-analysis, Evidence-based Medicine, Clinical Guidelines, Letter to the Editor, and Case Report.\u00a0Diabetes Asia Journal\u00a0is published under JHRC and covers\u00a0Diabetes Research, including NCDs, specifically in Central Asia, South Asia, Southeast Asia, and the Asia Pacific. 2. APC: Article processing charges are completely waived from Jan 2024 to Dec 2026. All the articles are Open Access and are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third-party material in this article are included in the article\u2019s Creative Commons license unless stated otherwise in a credit line to the material. To view a copy of this license, visit http:\/\/creativecommons.org\/licenses\/by\/4.0\/ 3. Diabetes Asia Journal routinely screens article submissions for plagiarism through https:\/\/www.ithenticate.com\/products\/crossref-similarity-check and does not accept manuscripts where plagiarism is found. 4. A repository A preprint may be deposited on the journal’s website, for which a DOI will be assigned and made available until the article is published. 5. Diabetes Asia Journal under JHRC is a publisher and a Member of Crossref with DOI: 10.62996 6. Focus and Scope The Diabetes Asia Journal (Diabetes Asia J) [ISSN 3048-8192 (Online) under JHRC (Publisher) serves as the Quarterly Journal. This esteemed, multidisciplinary, peer-reviewed, open-access journal facilitates the exchange of scientific information across the medical, dental, pharmaceutical, nursing, and biological sciences. JHRC publishes the Journal and does not impose any article processing or submission fees. Diabetes Asia J has an internationally recognized editorial team comprising selected scientists and clinical experts from diverse fields of basic and clinical medical science. We firmly adhere to the rigorous standards set by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) in all aspects of conducting, reporting, editing, and publishing scholarly research. Our mission at Diabetes Asia Journal is to swiftly disseminate ground-breaking experimental and clinical research findings that enhance healthcare outcomes. We publish various content, including editorials, original articles, review articles, short communications, case reports, methods and techniques, and letters to the editor. We invite high-quality submissions reflecting laboratory and basic science research and clinical investigations. Contributions involving animal models and in vitro assays are also welcome. Upon online submission, articles will undergo a rigorous peer review. Accepted manuscripts are published immediately to ensure rapid international dissemination of knowledge. All submitted manuscripts must include a statement affirming that all human studies have been thoroughly reviewed by the appropriate ethics committee and conducted under the ethical standards outlined in the Declaration of Helsinki and its subsequent amendments. Furthermore, it is mandatory to include a statement confirming that informed consent was obtained from all participants before they were included in the study. Reports on animal experiments must comply with the “Principles of Laboratory Animal Care”. The Editor-in-Chief reserves the unequivocal right to reject any manuscript that fails to meet these critical requirements. Each author listed must have made a significant contribution to the research. While our editorial team and referees are committed to ensuring the integrity of the published manuscripts, ultimate accountability for the accuracy and completeness of the reports lies solely with the authors. Authors are fully responsible for inaccuracies, misrepresentations, or failure to adhere to these stipulations. 7. Peer Review Process The Diabetes Asia Journal (Diabetes Asia J) employs a rigorous single-blind peer-review process to uphold the highest standards of research integrity. Each submission is evaluated by at least two to three expert reviewers who offer detailed critiques within two to four weeks. These reviewers meticulously assess the originality of the research, its impact on advancing the field, and the validity of the scientific methods employed. They identify any errors or shortcomings in the study\u2019s design and methodology, critically evaluate the significance of the results, and ensure all references cited are accurate and complete. This comprehensive review process ensures that only the most impactful and scientifically sound research is published, contributing to advancing diabetes science and care. Peer review comments will be available on the Journal’s website. 8. Publication Frequency The Diabetes Asia Journal (Diabetes Asia J) is a quarterly journal, committed to delivering cutting-edge research promptly. Each volume features a single comprehensive issue released once a year. What sets Diabetes Asia J apart is its dedication to rapid dissemination of knowledge\u2014we publish individual articles as soon as they are ready, featuring them in our “ahead of print” section. This innovative approach allows researchers and practitioners<\/p>\n","protected":false},"author":1,"featured_media":2063,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-374","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/pages\/374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/comments?post=374"}],"version-history":[{"count":2,"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/pages\/374\/revisions"}],"predecessor-version":[{"id":3761,"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/pages\/374\/revisions\/3761"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/media\/2063"}],"wp:attachment":[{"href":"https:\/\/www.diabetesasia.org\/journal\/wp-json\/wp\/v2\/media?parent=374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}